Lincomycin and tetracycline resistance in poultry. Review

Muhammad Jamal, Munazza Shareef and Sanaullah Sajid
Additional contact information
Muhammad Jamal: Institute of Pharmacy, Physiology & Pharmacology,University of Agriculture, 38040 Faisalabad, Pakistan
Munazza Shareef: Institute of Pharmacy, Physiology & Pharmacology,University of Agriculture, 38040 Faisalabad, Pakistan
Sanaullah Sajid: Institute of Microbiology, Faculty of veterinary science, University of Agriculture, Faisalabad, Pakistan

Matrix Science Pharma (MSP), 2017, vol. 1, issue 1, 33-38

Abstract: Antimicrobial agents are the most valuable means available for treating bacterial infections. Lincomycin and tetracycline are common brand having antibacterial activity. It is considered to be a cost-effective drugs because of its low cost, good activity against pathogenic anaerobic bacteria, favorable pharmacokinetic and pharmacodynamics. Antibiotic in the animal feed as growth promoters are primarily source of antibiotic resistance and stress factor for gut epithelium. Current studies will elaborate the advances in understanding toxicity induce by tetracycline and lincomycin on mucosal layer of gut of broiler. Following parameters such feed intake, weight gain and feed conversion ratio were studied on weekly basis which show FCR of the lincomycin group was greater as compared to tetracycline group and control group minimum FCR was found in tetracycline group. ND and IBD (New castle disease and Infectious bursal disease) titer was also affected.

Keywords: Lincomycin; Tetracycline; Feed Conversion Ratio; New Castle Disease; Infectious Bursal Disease; Immune Titer. (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://matrixscpharma.com/download/714/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:zib:zbnmsp:v:1:y:2017:i:1:p:33-38

DOI: 10.26480/msp.01.2017.33.38

Access Statistics for this article

Matrix Science Pharma (MSP) is currently edited by Professor. Dr. Urban John Arnold D’ Souza

More articles in Matrix Science Pharma (MSP) from Zibeline International Publishing
Bibliographic data for series maintained by Zibeline International Publishing ( this e-mail address is bad, please contact ).